| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-17 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-17 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.27 | 5e-15 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-10 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-08 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |